Astrid Weins, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Podocytes | 16 | 2024 | 402 | 2.560 |
Why?
|
Glomerulosclerosis, Focal Segmental | 13 | 2024 | 325 | 2.230 |
Why?
|
Actinin | 6 | 2019 | 163 | 0.880 |
Why?
|
Nephrosis, Lipoid | 3 | 2024 | 45 | 0.860 |
Why?
|
Proteinuria | 6 | 2022 | 594 | 0.800 |
Why?
|
Kidney Transplantation | 9 | 2024 | 4215 | 0.800 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2020 | 82 | 0.700 |
Why?
|
Kidney Diseases | 9 | 2024 | 2093 | 0.690 |
Why?
|
Autoantibodies | 3 | 2024 | 2119 | 0.670 |
Why?
|
Nephrotic Syndrome | 2 | 2024 | 391 | 0.670 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2020 | 649 | 0.580 |
Why?
|
Nephritis, Interstitial | 3 | 2023 | 154 | 0.570 |
Why?
|
Microfilament Proteins | 4 | 2007 | 1134 | 0.560 |
Why?
|
Actins | 7 | 2019 | 2049 | 0.510 |
Why?
|
Kidney Glomerulus | 7 | 2024 | 568 | 0.470 |
Why?
|
Membrane Proteins | 5 | 2024 | 7854 | 0.430 |
Why?
|
Kidney | 11 | 2024 | 7072 | 0.390 |
Why?
|
PAX2 Transcription Factor | 2 | 2024 | 86 | 0.340 |
Why?
|
Immunoglobulin kappa-Chains | 2 | 2020 | 169 | 0.340 |
Why?
|
Myocardium | 2 | 2020 | 4688 | 0.310 |
Why?
|
Cardiomyopathies | 1 | 2020 | 1945 | 0.300 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4546 | 0.300 |
Why?
|
Kidney Failure, Chronic | 2 | 2023 | 2469 | 0.300 |
Why?
|
Longevity | 1 | 2015 | 1050 | 0.290 |
Why?
|
Glomerulonephritis, IGA | 2 | 2024 | 62 | 0.270 |
Why?
|
TRPC Cation Channels | 2 | 2017 | 110 | 0.250 |
Why?
|
Glomerulonephritis, Membranoproliferative | 1 | 2023 | 40 | 0.230 |
Why?
|
Epithelial Cells | 3 | 2019 | 3665 | 0.220 |
Why?
|
Apolipoproteins A | 1 | 2023 | 95 | 0.220 |
Why?
|
Nerve Tissue Proteins | 2 | 2015 | 4409 | 0.220 |
Why?
|
Mice, Knockout | 8 | 2024 | 14396 | 0.200 |
Why?
|
BK Virus | 1 | 2022 | 124 | 0.200 |
Why?
|
Nephritis | 1 | 2022 | 149 | 0.200 |
Why?
|
Biopsy | 7 | 2024 | 6775 | 0.190 |
Why?
|
Polyomavirus Infections | 1 | 2022 | 195 | 0.180 |
Why?
|
Acute Kidney Injury | 3 | 2022 | 1935 | 0.180 |
Why?
|
Indenes | 1 | 2021 | 58 | 0.180 |
Why?
|
Point Mutation | 1 | 2005 | 1594 | 0.180 |
Why?
|
Lipid Peroxidation | 1 | 2021 | 271 | 0.170 |
Why?
|
Heptanes | 1 | 2019 | 8 | 0.170 |
Why?
|
Tumor Virus Infections | 1 | 2022 | 438 | 0.170 |
Why?
|
Ubiquinone | 1 | 2021 | 183 | 0.170 |
Why?
|
Glomerulonephritis | 2 | 2014 | 337 | 0.170 |
Why?
|
Molecular Mimicry | 1 | 2019 | 200 | 0.160 |
Why?
|
Ataxia | 1 | 2021 | 305 | 0.160 |
Why?
|
Diabetic Nephropathies | 2 | 2024 | 988 | 0.160 |
Why?
|
Muscle Weakness | 1 | 2021 | 413 | 0.150 |
Why?
|
Receptors, Immunologic | 1 | 2024 | 1434 | 0.150 |
Why?
|
Kidney Tubules, Proximal | 1 | 2019 | 382 | 0.150 |
Why?
|
Hypertension, Renal | 1 | 2017 | 141 | 0.150 |
Why?
|
Organoids | 2 | 2022 | 729 | 0.140 |
Why?
|
Doxorubicin | 1 | 2024 | 2207 | 0.140 |
Why?
|
Mitochondrial Diseases | 1 | 2021 | 340 | 0.140 |
Why?
|
Cytoplasm | 1 | 2001 | 1518 | 0.140 |
Why?
|
Amyloidosis | 1 | 2023 | 818 | 0.140 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2023 | 2296 | 0.140 |
Why?
|
Vesicular Transport Proteins | 1 | 2019 | 374 | 0.140 |
Why?
|
Immunoglobulin A | 1 | 2020 | 978 | 0.140 |
Why?
|
Mutation, Missense | 2 | 2024 | 2563 | 0.130 |
Why?
|
Muscle Proteins | 1 | 2001 | 1152 | 0.130 |
Why?
|
Immunoconjugates | 2 | 2014 | 949 | 0.130 |
Why?
|
Graft Rejection | 5 | 2023 | 4423 | 0.130 |
Why?
|
Indazoles | 1 | 2017 | 302 | 0.130 |
Why?
|
Fluorescent Antibody Technique | 1 | 2020 | 2473 | 0.130 |
Why?
|
Immunoglobulin M | 1 | 2020 | 1529 | 0.120 |
Why?
|
Nanomedicine | 1 | 2017 | 290 | 0.120 |
Why?
|
Albuminuria | 2 | 2019 | 659 | 0.120 |
Why?
|
Fluorocarbons | 1 | 2019 | 483 | 0.120 |
Why?
|
Glomerular Basement Membrane | 1 | 2013 | 36 | 0.120 |
Why?
|
Phosphatidylserines | 1 | 2015 | 188 | 0.120 |
Why?
|
Bone Resorption | 1 | 2018 | 720 | 0.110 |
Why?
|
Pyrazoles | 2 | 2022 | 1992 | 0.110 |
Why?
|
Lysosomes | 1 | 2019 | 919 | 0.110 |
Why?
|
MAP Kinase Signaling System | 1 | 2021 | 1483 | 0.110 |
Why?
|
Humans | 42 | 2024 | 760261 | 0.110 |
Why?
|
Benzamides | 1 | 2019 | 1369 | 0.110 |
Why?
|
Membrane Glycoproteins | 1 | 2024 | 3731 | 0.110 |
Why?
|
Mice | 15 | 2024 | 81216 | 0.110 |
Why?
|
Endothelial Cells | 2 | 2023 | 3537 | 0.110 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2013 | 85 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2014 | 2895 | 0.110 |
Why?
|
Amino Acid Substitution | 2 | 2007 | 1737 | 0.110 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2013 | 193 | 0.110 |
Why?
|
Palmitic Acid | 1 | 2013 | 149 | 0.100 |
Why?
|
Cell Nucleus | 1 | 2001 | 2909 | 0.100 |
Why?
|
Microscopy, Electron, Transmission | 2 | 2019 | 697 | 0.100 |
Why?
|
Microscopy | 1 | 2017 | 881 | 0.100 |
Why?
|
Recurrence | 1 | 2024 | 8487 | 0.100 |
Why?
|
Male | 20 | 2024 | 359413 | 0.100 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2013 | 235 | 0.100 |
Why?
|
Animals | 18 | 2024 | 167940 | 0.100 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1503 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2019 | 1843 | 0.090 |
Why?
|
Macrophages | 2 | 2024 | 5745 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2021 | 2052 | 0.090 |
Why?
|
Stress Fibers | 1 | 2010 | 55 | 0.090 |
Why?
|
Phosphoproteins | 1 | 2019 | 2441 | 0.090 |
Why?
|
Molecular Imaging | 1 | 2017 | 817 | 0.090 |
Why?
|
Mutation | 7 | 2023 | 29950 | 0.090 |
Why?
|
Gelsolin | 1 | 2010 | 189 | 0.090 |
Why?
|
Dynamins | 1 | 2010 | 138 | 0.090 |
Why?
|
Protein Binding | 6 | 2019 | 9336 | 0.090 |
Why?
|
Mutagenesis | 2 | 2005 | 1234 | 0.080 |
Why?
|
Phagocytosis | 1 | 2015 | 1536 | 0.080 |
Why?
|
Models, Chemical | 2 | 2008 | 614 | 0.080 |
Why?
|
Consanguinity | 1 | 2011 | 456 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4554 | 0.080 |
Why?
|
Cytoskeleton | 2 | 2013 | 1167 | 0.080 |
Why?
|
Homozygote | 2 | 2011 | 1786 | 0.080 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18134 | 0.080 |
Why?
|
Oncogene Proteins | 1 | 2013 | 721 | 0.080 |
Why?
|
Amino Acid Sequence | 6 | 2015 | 13456 | 0.080 |
Why?
|
HEK293 Cells | 4 | 2021 | 4264 | 0.080 |
Why?
|
Interleukin-1beta | 1 | 2014 | 999 | 0.080 |
Why?
|
Binding Sites | 3 | 2008 | 6050 | 0.080 |
Why?
|
Mice, Inbred C57BL | 4 | 2024 | 22025 | 0.070 |
Why?
|
Female | 17 | 2024 | 391011 | 0.070 |
Why?
|
Molecular Sequence Data | 6 | 2015 | 17628 | 0.070 |
Why?
|
HLA Antigens | 2 | 2023 | 1369 | 0.070 |
Why?
|
Cytokines | 1 | 2022 | 7345 | 0.070 |
Why?
|
Pedigree | 3 | 2014 | 4577 | 0.070 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2013 | 1314 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 2 | 2007 | 3735 | 0.070 |
Why?
|
Cell Proliferation | 3 | 2024 | 10434 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2010 | 2755 | 0.070 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9388 | 0.060 |
Why?
|
Fibroblasts | 1 | 2015 | 4091 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 2927 | 0.060 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 6226 | 0.060 |
Why?
|
rac1 GTP-Binding Protein | 2 | 2017 | 242 | 0.060 |
Why?
|
Apoptosis | 2 | 2024 | 9497 | 0.060 |
Why?
|
Models, Molecular | 3 | 2014 | 5429 | 0.060 |
Why?
|
Adult | 8 | 2024 | 219847 | 0.060 |
Why?
|
Cohort Studies | 3 | 2021 | 41317 | 0.060 |
Why?
|
Disease Progression | 3 | 2018 | 13505 | 0.060 |
Why?
|
Mice, Mutant Strains | 1 | 2007 | 1760 | 0.060 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2007 | 1694 | 0.060 |
Why?
|
Microscopy, Electron | 2 | 2020 | 2558 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2014 | 3207 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 1 | 2005 | 17766 | 0.060 |
Why?
|
Protein Structure, Tertiary | 2 | 2007 | 3800 | 0.060 |
Why?
|
Focal Adhesions | 1 | 2023 | 115 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
Child, Preschool | 2 | 2024 | 42034 | 0.050 |
Why?
|
HLA-DQ Antigens | 1 | 2023 | 211 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
Glutamic Acid | 1 | 2007 | 1166 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4437 | 0.050 |
Why?
|
Thiazolidines | 1 | 2001 | 69 | 0.050 |
Why?
|
Obesity | 1 | 2024 | 12915 | 0.050 |
Why?
|
Nuclear Localization Signals | 1 | 2001 | 77 | 0.050 |
Why?
|
STAT Transcription Factors | 1 | 2022 | 188 | 0.050 |
Why?
|
Azetidines | 1 | 2022 | 137 | 0.050 |
Why?
|
Janus Kinases | 1 | 2022 | 250 | 0.050 |
Why?
|
Heating | 1 | 2001 | 101 | 0.050 |
Why?
|
Alkyl and Aryl Transferases | 1 | 2021 | 86 | 0.050 |
Why?
|
Middle Aged | 7 | 2024 | 220175 | 0.050 |
Why?
|
Static Electricity | 2 | 2014 | 261 | 0.050 |
Why?
|
Lupus Nephritis | 1 | 2024 | 318 | 0.050 |
Why?
|
Heat-Shock Response | 1 | 2001 | 179 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 8945 | 0.040 |
Why?
|
Probability | 1 | 2005 | 2476 | 0.040 |
Why?
|
Imidazoline Receptors | 1 | 2019 | 13 | 0.040 |
Why?
|
Fibronectins | 1 | 2023 | 721 | 0.040 |
Why?
|
Child | 4 | 2024 | 79758 | 0.040 |
Why?
|
Kinetics | 1 | 2007 | 6378 | 0.040 |
Why?
|
Activating Transcription Factor 6 | 1 | 2019 | 29 | 0.040 |
Why?
|
Clone Cells | 1 | 2023 | 1663 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2013 | 18968 | 0.040 |
Why?
|
Isoantibodies | 1 | 2023 | 661 | 0.040 |
Why?
|
Sequence Analysis, DNA | 2 | 2011 | 4717 | 0.040 |
Why?
|
Purines | 1 | 2022 | 601 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2021 | 15680 | 0.040 |
Why?
|
Luminescent Proteins | 1 | 2001 | 835 | 0.040 |
Why?
|
Crystallization | 1 | 2019 | 533 | 0.040 |
Why?
|
Hypokalemia | 1 | 2019 | 153 | 0.040 |
Why?
|
Sulfonamides | 2 | 2022 | 1973 | 0.040 |
Why?
|
Adenoviridae | 1 | 2022 | 1084 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2023 | 1446 | 0.040 |
Why?
|
Immunosuppressive Agents | 2 | 2023 | 4168 | 0.040 |
Why?
|
Rats, Inbred Dahl | 1 | 2017 | 34 | 0.040 |
Why?
|
Rats, Transgenic | 1 | 2017 | 69 | 0.040 |
Why?
|
Oxides | 1 | 2019 | 400 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13249 | 0.040 |
Why?
|
Ferric Compounds | 1 | 2019 | 378 | 0.040 |
Why?
|
Muscle, Smooth | 1 | 2001 | 924 | 0.040 |
Why?
|
Frameshift Mutation | 1 | 2019 | 388 | 0.040 |
Why?
|
Calcification, Physiologic | 1 | 2018 | 170 | 0.040 |
Why?
|
Unfolded Protein Response | 1 | 2019 | 233 | 0.040 |
Why?
|
Histological Techniques | 1 | 2017 | 194 | 0.040 |
Why?
|
Paraproteinemias | 1 | 2019 | 246 | 0.040 |
Why?
|
Autopsy | 1 | 2020 | 1007 | 0.030 |
Why?
|
Cell Line | 2 | 2019 | 15626 | 0.030 |
Why?
|
Microspheres | 1 | 2019 | 785 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2019 | 3443 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 6067 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2001 | 2056 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1828 | 0.030 |
Why?
|
Protein Transport | 1 | 2001 | 1966 | 0.030 |
Why?
|
Models, Biological | 2 | 2013 | 9468 | 0.030 |
Why?
|
Regeneration | 1 | 2024 | 1506 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58947 | 0.030 |
Why?
|
Mucin-1 | 1 | 2019 | 539 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2023 | 3160 | 0.030 |
Why?
|
Thiazoles | 1 | 2001 | 1509 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2001 | 1395 | 0.030 |
Why?
|
Inflammation | 3 | 2022 | 10757 | 0.030 |
Why?
|
Phenotype | 2 | 2024 | 16543 | 0.030 |
Why?
|
Creatinine | 1 | 2019 | 1906 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2536 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2019 | 2220 | 0.030 |
Why?
|
Hydrocarbons, Fluorinated | 1 | 2013 | 38 | 0.030 |
Why?
|
Protamines | 1 | 2013 | 111 | 0.030 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2013 | 83 | 0.030 |
Why?
|
Protein Conformation | 2 | 2014 | 3969 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2019 | 11480 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 11902 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 2013 | 120 | 0.030 |
Why?
|
Genetic Testing | 1 | 2005 | 3530 | 0.030 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2013 | 190 | 0.030 |
Why?
|
Benzylamines | 1 | 2013 | 248 | 0.030 |
Why?
|
Protective Agents | 1 | 2013 | 150 | 0.030 |
Why?
|
Dexamethasone | 1 | 2019 | 1928 | 0.030 |
Why?
|
Graft Survival | 1 | 2023 | 3793 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2019 | 9531 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2017 | 734 | 0.020 |
Why?
|
Fibroblast Growth Factors | 1 | 2018 | 867 | 0.020 |
Why?
|
Muscle, Skeletal | 2 | 2010 | 4923 | 0.020 |
Why?
|
Benzoates | 1 | 2013 | 212 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2003 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2019 | 2378 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2018 | 1797 | 0.020 |
Why?
|
Urogenital Abnormalities | 1 | 2014 | 256 | 0.020 |
Why?
|
Iron | 1 | 2019 | 1786 | 0.020 |
Why?
|
Genotype | 1 | 2005 | 12959 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2014 | 1168 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2014 | 11064 | 0.020 |
Why?
|
RNA Interference | 1 | 2019 | 2846 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14656 | 0.020 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2014 | 438 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1799 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3810 | 0.020 |
Why?
|
Rats | 2 | 2017 | 23695 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2021 | 2218 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2018 | 2178 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6499 | 0.020 |
Why?
|
Calcium Signaling | 1 | 2013 | 731 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2019 | 20048 | 0.020 |
Why?
|
Gene Expression | 1 | 2001 | 7592 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1617 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2368 | 0.020 |
Why?
|
Phosphorylation | 1 | 2019 | 8314 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2019 | 3601 | 0.020 |
Why?
|
Breast | 1 | 2017 | 1980 | 0.020 |
Why?
|
Ubiquitination | 1 | 2013 | 1010 | 0.020 |
Why?
|
Neuropeptides | 1 | 2013 | 941 | 0.020 |
Why?
|
Computer Simulation | 2 | 2014 | 6210 | 0.020 |
Why?
|
Cell Death | 1 | 2013 | 1670 | 0.020 |
Why?
|
Viscosity | 1 | 2008 | 335 | 0.020 |
Why?
|
Ultracentrifugation | 1 | 2007 | 183 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5790 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2013 | 2222 | 0.020 |
Why?
|
Incidence | 1 | 2005 | 21378 | 0.020 |
Why?
|
X-Ray Diffraction | 1 | 2007 | 420 | 0.020 |
Why?
|
Age of Onset | 1 | 2014 | 3302 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2013 | 3604 | 0.020 |
Why?
|
Gene Silencing | 1 | 2013 | 1511 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2001 | 12762 | 0.020 |
Why?
|
Elasticity | 1 | 2008 | 652 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3568 | 0.020 |
Why?
|
Aged | 4 | 2024 | 168995 | 0.020 |
Why?
|
Contrast Media | 1 | 2019 | 5301 | 0.020 |
Why?
|
Endocytosis | 1 | 2010 | 960 | 0.020 |
Why?
|
Signal Transduction | 2 | 2022 | 23363 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2013 | 2214 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4109 | 0.020 |
Why?
|
Triglycerides | 1 | 2013 | 2476 | 0.020 |
Why?
|
Up-Regulation | 1 | 2014 | 4127 | 0.020 |
Why?
|
Monocytes | 1 | 2014 | 2574 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2007 | 1230 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12968 | 0.010 |
Why?
|
HeLa Cells | 1 | 2010 | 3105 | 0.010 |
Why?
|
Rabbits | 1 | 2010 | 4773 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 80301 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12602 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2250 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 2007 | 1979 | 0.010 |
Why?
|
Calcium-Binding Proteins | 1 | 2007 | 1066 | 0.010 |
Why?
|
Base Sequence | 1 | 2014 | 12447 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3613 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10185 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11708 | 0.010 |
Why?
|
Heterozygote | 1 | 2008 | 2797 | 0.010 |
Why?
|
Adolescent | 3 | 2014 | 87747 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8621 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 16905 | 0.010 |
Why?
|
Young Adult | 2 | 2014 | 58673 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13629 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 15766 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 64947 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39254 | 0.010 |
Why?
|
Prospective Studies | 1 | 2014 | 54263 | 0.010 |
Why?
|